Bernu Kliniska Universitates Slimnica VSIA — Clinical Trial Site

21 Registered trials

7 Currently recruiting

Organisation

Bernu Kliniska Universitates Slimnica VSIA

Location

Riga, Latvia

Identifier

ORG-100039045

Address

Zemgales Priekspilseta, Vienibas Gatve 45, 1004, Latvia

Departments

2510: Neurology Department
Bernu kirurgijas klinika
Bernu Kliniska Universitates Slimnica VSIA
Children‘s Neurology and Neurosurgery Clinic
Clinic for Pediatric Neurology and Neurosurgery
Clinic of Paediatric Surgery
Epilepsy and Sleep Medicine Centre
N/A
NA
Pediatric Oncology and Hematology
Rehabilitation
Surgery

Clinical trials at this site (21)

Search interface

Clinical and economical efficiency and safety and inflammation parameter correlations study of conservative treatment of non-complicated acu… Pending

2025-520496-19-00 Acute non-complicated appendicitis in patients aged 7 t 6
“Study of pain syndrome and clinical-biochemical parameters in children aged 7 to 18 years in cases of non-surgical treatment of uncomplicat… Pending

2025-520964-16-00 uncomplicated acute appendicitis 11
A Phase 3 Open-Label Study to Investigate bexicaserin (LP352) in Children and Adults with Developmental and Epileptic Encephalopathy Recruiting

2024-514974-39-00 Developmental and Epileptic Encephalopathies (DEEs) 5 2025-10-10
CHIP-AML22/Quizartinib sub-study: study of the safety and efficacy of quizartinib in children and adolescents with FLT3-ITD positive AML wit… Recruiting

2023-505000-27-01 newly diagnosed pediatric FLT3-ITD positive and NPM1 wi 4 2023-12-29
Open-label, long-term safety, efficacy, and pharmacokinetics study of vibegron in pediatric subjects 2 years to < 18 years of age with NDO a… Recruiting

2024-513995-16-00 Neurogenic Detrusor Overactivity (NDO) 10 2023-07-28
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis Recruiting

2024-511686-11-00 Multiple Sclerosis in pediatric patients 5 2021-10-05
A Phase 3, placebo-controlled study to investigate LP352 in children and adults with Developmental and Epileptic Encephalopathies Recruiting

2024-516412-17-00 Developmental and Epileptic Encephalopathies (DEE) 5 2025-08-26
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) Recruiting

2024-514937-39-00 Dravet Syndrome 5 2025-05-20
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML) Recruiting

2023-504999-25-00 Acute Myeloid Leukemia 5 2023-07-14
A Randomized, Double Blind, Active-Controlled Study on Efficacy and Safety of TEV-56248 in Patients with Asthma Ended

2023-505435-12-00 Asthma 5 2024-06-04
A research study looking at long-term treatment with Mim8 in people with haemophilia A (FRONTIER 4) Ended

2022-502215-10-00 Haemophilia A (with or without inhibitors) 5 2023-05-04
A research study to compare somapacitan once a week with Norditropin® once a day in children who need help to grow Ended

2023-506927-27-00 Children with short stature either born small for gesta 5 2022-08-29
A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison with Fingolimod in Children and Adolescents with Relapsing-Remitting Mu… Ended

2023-506516-40-00 Relapsing-Remitting Multiple Sclerosis 5 2022-02-11
A research study in children born small and who stayed small. Treatment is somapacitan once a week compared to Norditropin® once a day Ended

2023-506830-66-00 SGA - small for gestational age children 4 2019-05-29
A Multi-national Phase IIIb Trial to Determine the Safety and Efficacy of STALORAL® Birch 300 IR in Children and Adolescents 5 to 17 Years o… Ended

2023-509833-38-00 Birch Pollen-induced Allergic Rhinoconjunctivitis 5 2023-09-20
A study on the immune response and safety of a combined measles, mumps, rubella, chickenpox vaccine compared to a marketed combined vaccine,… Ended

2022-501564-18-00 Healthy volunteers (prevention of measles, mumps, rubel 4 2023-07-31
A Multicenter, Open-Label, Evaluator-Blinded, Randomized Study to Evaluate the Safety and Tolerability of Single-Dose IV Oritavancin for the… Ended

2024-516385-10-00 Acute Bacterial Skin and Skin Structure Infections 4 2023-05-02
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose ranging Study to Assess the Efficacy and Safety of CDX 0159 in Patients with Ch… Ended

2024-516988-87-00 Chronic Inducible Urticaria 4 2022-11-09
A clinical study to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity in children and adolescents with… Ended

2023-503420-19-00 Pediatric lower limb (LL) spasticity (SP) caused by cer 5 2022-10-12
Open-label extesnion study of soticlestat in Dravet and Lennox-Gastaut Syndromes Ended

2022-502802-34-00 Dravet and Lennox-Gastaut Syndromes 5 2022-04-05
A research study in children with low level of hormone to grow. Treatment is somapacitan once a week compared to Norditropin® once a day Ended

2023-506829-11-00 Growth Hormone Deficiency in children 5 2019-05-29